Dr. Reddy's Laboratories Limited Cash Flow Quality Index
Dr. Reddy's Laboratories Limited cash flow quality index. Dr. Reddy's Laboratories Limited (RDDA) has a Cash Flow Quality Index of 0.90x as of December 2025. Operating cash flow of €10.91 Billion is below net income of €12.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Dr. Reddy's Laboratories Limited service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Dr. Reddy's Laboratories Limited (2017–2025)
Cash flow quality index of Dr. Reddy's Laboratories Limited from 2017 to 2025. Historical Cash Flow Quality Index for Dr. Reddy's Laboratories Limited across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See RDDA equity to assets ratio to measure how much of total assets are equity-financed.
Dr. Reddy's Laboratories Limited Cash Flow Quality Index by Year (2017–2025)
Dr. Reddy's Laboratories Limited cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for Dr. Reddy's Laboratories Limited. For the full cash flow conversion analysis, see Dr. Reddy's Laboratories Limited cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | €46.43 Billion | €56.54 Billion | ▲ +0.8% |
| 2024 | 0.81x | €45.43 Billion | €55.78 Billion | ▼ -37.7% |
| 2023 | 1.31x | €58.88 Billion | €45.07 Billion | ▲ +9.5% |
| 2022 | 1.19x | €28.11 Billion | €23.57 Billion | ▼ -36.0% |
| 2021 | 1.86x | €35.70 Billion | €19.15 Billion | ▲ +21.8% |
| 2020 | 1.53x | €29.84 Billion | €19.50 Billion | ▲ +0.2% |
| 2019 | 1.53x | €28.70 Billion | €18.80 Billion | ▼ -16.9% |
| 2018 | 1.84x | €18.03 Billion | €9.81 Billion | ▲ +2.9% |
| 2017 | 1.79x | €21.51 Billion | €12.04 Billion | — |